Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

NCT05751031 is registered in ClinicalTrials.gov with Fondazione Penta UK as lead sponsor.

NCT NCT05751031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05751031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
Lead sponsor
Fondazione Penta UK
Phase
Observational
Overall status
Unknown status
Start date
February 20, 2023
Completion date
February 20, 2024
Enrollment
1,200 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections